More than half of children and adolescents receiving active oncologic treatment had modifications to cancer-directed therapy
Which Cancer Patients Need a COVID-19 Booster Shot Most?
NCCN guidance says several groups should be considered eligible immediately for a third dose of either of the mRNA vaccines
COVID-19 Immune Response Appears Strong in Cancer Patients
Vast majority show seropositivity four months after the second COVID-19 vaccine dose
Enrollment in Cancer Treatment Trials Largely Unchanged by Pandemic
However, there was a significant decrease in enrollment for cancer control and prevention trials
Cancer Screenings Disrupted During Pandemic at Federally Qualified Health Centers
Despite resumption of in-person screenings, catching up from COVID-19 disruptions will be difficult
Should Changes Made to Clinical Trials During Pandemic Be Kept?
Changes were recommended to preserve potential patient benefit while minimizing risks associated with COVID-19
Remote Monitoring System Reduces Chemotherapy Symptom Burden
Significant reductions seen for global distress index, psychological symptoms, physical symptoms of Memorial Symptom Assessment Scale
Pfizer-BioNTech COVID-19 Vaccine Safe, Effective in Cancer Patients
Pronounced lag in antibody production after the first dose found versus noncancer controls
Many Young Cancer Survivors Report COVID-19 Vaccine Hesitancy
37.1 percent of adolescent and young adult cancer survivors report vaccine hesitancy; higher odds of hesitancy for females
Convalescent Plasma May Cut Deaths in Hematologic Cancer and COVID-19
Lower 30-day mortality seen in hospitalized adults, including those admitted to ICU, requiring mechanical ventilation